VANGUARD GROUP INC - QUALIGEN THERAPEUTICS INC ownership

QUALIGEN THERAPEUTICS INC's ticker is QLGN and the CUSIP is 74754R103. A total of 32 filers reported holding QUALIGEN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of QUALIGEN THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$274,000
-53.1%
1,026,2720.0%0.00%
Q2 2022$584,000
-24.3%
1,026,272
-12.2%
0.00%
Q1 2022$771,000
-38.4%
1,168,9720.0%0.00%
Q4 2021$1,251,000
-18.2%
1,168,972
-0.6%
0.00%
Q3 2021$1,529,000
-24.9%
1,175,946
+14.8%
0.00%
Q2 2021$2,037,000
+150.6%
1,023,911
+239.9%
0.00%
Q1 2021$813,000
-10.4%
301,1950.0%0.00%
Q4 2020$907,000
-40.1%
301,195
-1.6%
0.00%
Q3 2020$1,515,000305,9510.00%
Other shareholders
QUALIGEN THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
CRA Financial Services, LLC 19,957$60,0000.02%
OCCUDO QUANTITATIVE STRATEGIES LP 15,800$48,0000.02%
WEDBUSH SECURITIES INC 32,228$97,0000.01%
QS Investors, LLC 82,000$247,0000.00%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 62,500$188,0000.00%
Retirement Group, LLC 2,500$7,0000.00%
Cetera Investment Advisers 40,275$121,0000.00%
Your Advocates Ltd., LLP 200$1,0000.00%
UBS Group AG 2,467$7,0000.00%
IFP Advisors, Inc 0$00.00%
View complete list of QUALIGEN THERAPEUTICS INC shareholders